<div id="readability-page-1"><p>In a report released yesterday,  from CICC maintained a Buy rating on Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H, with a price target of <span id="expert-recommendation-target">HK$550.00</span>. The company’s shares closed yesterday at HK$417.60.</p><h3>TipRanks Cyber Monday Sale</h3><ul><li> Claim 60% off TipRanks Premium  for data-backed insights and research tools you need to invest with confidence.  </li><li>  Subscribe to TipRanks' Smart Investor Picks  and see our data in action through our high-performing model portfolio - <u> now also 60% off </u></li></ul>  <p>The word on The Street in general, suggests a Strong Buy analyst consensus rating for Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H with a HK$551.37 average price target, implying a 32.03% upside from current levels. In a report released on December 3, Bernstein also initiated coverage with a Buy rating on the stock with a HK$545.00 price target.</p></div>

06990

<p>CICC maintains a Buy rating on Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H with a price target of HK$550.00. The stock closed at HK$417.60, suggesting a 32.03% upside. Bernstein also initiated coverage with a Buy rating and a HK$545.00 target. Analysts generally rate the stock as a Strong Buy with an average target of HK$551.37.</p>

CICC Keeps Their Buy Rating on Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H (6990)